Kidney toxicities associated with novel cancer therapies Journal Article


Authors: Lefebvre, J.; Glezerman, I. G.
Article Title: Kidney toxicities associated with novel cancer therapies
Abstract: Targeted therapies that act via unique molecular pathways and interfere with cancer cell growth and tumor progression have dramatically changed the cancer treatment paradigm. However, although, ideally, these therapies intend to target only cancer cells, they do often affect nonmalignant tissue. Numerous renal side effects have been reported to date. This article will review clinical presentation, presumed pathophysiology, and treatment of kidney side effects of targeted therapies. Feasibility of the continuation of cancer therapy despite renal toxicity will also be addressed. © 2017
Keywords: acute kidney failure; immunotherapy; targeted therapy; anti-angiogenic therapy; kidney toxicity
Journal Title: Advances in Chronic Kidney Disease
Volume: 24
Issue: 4
ISSN: 1548-5595
Publisher: Elsevier Inc.  
Date Published: 2017-07-01
Start Page: 233
End Page: 240
Language: English
DOI: 10.1053/j.ackd.2017.05.006
PROVIDER: scopus
PUBMED: 28778363
DOI/URL:
Notes: Review -- Export Date: 5 September 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors